Abstract
Multiple myeloma (MM) is an incurable plasma cell malignancy that evolves from a premalignant condition termed monoclonal gammopathy of undetermined significance (MGUS). MM is the most frequent cancer that involves the skeleton, with 90% of patients eventually developing bone lesions. Bone involvement causes devastating consequences for MM patients, including pathological fractures that occur in 50%-60% of patients and are present in 20% of patients at diagnosis. These fractures cause severe bone pain and increase mortality risk by 20%. MM increases localized bone resorption and suppresses bone formation, causing purely lytic lesions that usually do not repair. MGUS also affects the skeleton, with MGUS patients having a 1.7-fold increased fracture incidence compared to age-matched controls. In this chapter the mechanisms responsible for the impact of MGUS and MM on the skeleton and therapeutic approaches to prevent and treat MGUS- and MM-induced bone disease are discussed.
Original language | English (US) |
---|---|
Title of host publication | Marcus and Feldman’s Osteoporosis |
Publisher | Elsevier |
Pages | 1421-1437 |
Number of pages | 17 |
ISBN (Electronic) | 9780128130735 |
DOIs | |
State | Published - Jan 1 2020 |
Keywords
- Bone disease
- Bone pain
- MGUS
- MMBD
- Multiple myeloma
ASJC Scopus subject areas
- General Agricultural and Biological Sciences
- General Biochemistry, Genetics and Molecular Biology
- General Medicine